Janssen Therapeutics LINCC™ Program Continues Its Commitment to Underserved Populations With Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S. /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, today announced the 16 organizations that will receive a charitable contribution from its Linking In-Need ... (more)
http://www.biospace.com/news_story.aspx?StoryID=294267&full=1
http://www.biospace.com/news_story.aspx?StoryID=294267&full=1
No comments:
Post a Comment